Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05666479 · ClinicalTrials.gov registry record
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
A clinical trial of Diabetes Mellitus, Type 2 and Arthroplasty, Replacement, Knee, sponsored by Stony Brook University.
- Active
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT05666479 is a study of Diabetes Mellitus, Type 2 and Arthroplasty, Replacement, Knee that is active but no longer recruiting, run by Stony Brook University. The registered enrollment target is 32 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05666479, a study of Diabetes Mellitus, Type 2 and Arthroplasty, Replacement, Knee, is active but no longer recruiting, sponsored by Stony Brook University.
- ACTIVE NOT RECRUITING
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze the efficacy and accuracy of real-time continuous glucose monitoring devices (rtCGM) in patients with Type 2 diabetes undergoing inpatient elective hip or knee surgery in the pre-, peri-, and post-operative setting at Stony Brook University Hospital (SBUH).
Conditions Studied
Interventions
- DEVICE Dexcom G6 Pro Continuous Glucose Monitor (CGM)
Study Locations (1)
New York
- Stony Brook University - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2024-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05666479
The ClinicalTrials.gov registry entry for NCT05666479 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Dexcom G6 Pro Continuous Glucose Monitor (CGM) is the first listed.
NCT05666479 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05666479 about?
NCT05666479 is a clinical study titled "CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery". The purpose of this study is to analyze the efficacy and accuracy of real-time continuous glucose monitoring devices (rtCGM) in patients with Type 2 diabetes undergoing inpatient elective hip or knee surgery in the pre-, peri-, and post-operative setting at Stony Brook University Hospital (SBUH).
What is the current status of trial NCT05666479?
This trial is currently active not recruiting. The enrollment target is 32 participants. The study started on 2022-09-09. Estimated completion is 2024-09.
What conditions does trial NCT05666479 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip.
What interventions are being tested in trial NCT05666479?
The interventions under investigation include: Dexcom G6 Pro Continuous Glucose Monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT05666479?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05666479 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.